Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Marchex (MCHX) EBT (2016 - 2025)

Marchex (MCHX) has disclosed EBT for 16 consecutive years, with -$2.4 million as the latest value for Q4 2025.

  • For Q4 2025, EBT fell 47.12% year-over-year to -$2.4 million; the TTM value through Dec 2025 reached -$5.2 million, down 12.9%, while the annual FY2025 figure was -$5.2 million, 12.9% down from the prior year.
  • EBT was -$2.4 million for Q4 2025 at Marchex, down from -$993000.0 in the prior quarter.
  • The five-year high for EBT was $3.3 million in Q3 2021, with the low at -$5.3 million in Q1 2021.
  • Historically, EBT has averaged -$1.5 million across 5 years, with a median of -$1.5 million in 2022.
  • The largest annual shift saw EBT skyrocketed 157.53% in 2021 before it crashed 463.74% in 2022.
  • Over 5 years, EBT stood at -$615000.0 in 2021, then crashed by 463.74% to -$3.5 million in 2022, then surged by 68.21% to -$1.1 million in 2023, then plummeted by 46.73% to -$1.6 million in 2024, then plummeted by 47.12% to -$2.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were -$2.4 million in Q4 2025, -$993000.0 in Q3 2025, and $90000.0 in Q2 2025.